In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ariad Pharmaceuticals (Luxembourg) SARL

Division of Incyte Corp.

Latest From Ariad Pharmaceuticals (Luxembourg) SARL

Ironwood Being Split In Two: Is Move To Thwart Activist Investor Sarissa?

Move will spin out sGC assets into solo listed group while smaller Ironwood will focus on GI diseases and abdominal pain.

Business Strategies Commercial

Deals Shaping The Medical Industry, June 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2016.

BioPharmaceutical Medical Device

Deal Watch: Mylan Counts On A Renaissance For Expansion

European markets are the name of the game as Ariad sells its European business to Incyte, Spain's Grupo Ferrer buys out Alexza, Italy's Chiesi bags a suite of CV drugs from The Medicines Co. and Swiss kidney disease specialist Vifor Fresenius takes up Opko's Rayaldee.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Luxembourg
  • Parent & Subsidiaries
  • Incyte Corp.
  • Senior Management
  • Contact Info
  • Ariad Pharmaceuticals (Luxembourg) SARL